Key Segments:
By Software Type
-
Diagnostic
-
Therapeutic
-
Monitoring
-
Clinical Decision Support
-
Workflow and Administrative
By Clinical Specialty
-
Radiology and Imaging
-
Cardiology
-
Neurology
-
Pathology
-
Ophthalmology
-
Oncology
-
Others
By End User
-
Hospitals
-
Ambulatory Care Centers
-
Diagnostic Laboratories
-
Home Healthcare Settings
-
Specialty Clinics
By Deployment Mode
-
Cloud-Based
-
On-Premises
-
Hybrid
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market includes Aidoc, Viz.ai, Qure.ai, Lunit, RapidAI, Heartflow, Cleerly, Brainomix, Eyenuk, Digital Diagnostics, Tempus AI, Ultromics, Us2.ai, Harrison.ai, RadNet, Sectra, Eko Health, AliveCor, Philips and iRhythm, among others. These companies compete on the number of cleared indications, clinical evidence and workflow integration.
The main opportunities lie in generative artificial intelligence for report drafting, new cardiology, pathology and ophthalmology indications, and home-based monitoring. Hybrid deployment and platform marketplaces add further potential.
The key growth factor is the gap between clinical workload and workforce supply, together with a steady flow of regulatory clearances that widen the range of usable algorithms.
By software type, the Diagnostic segment dominated the market with approximately 39.28% share in 2025, supported by the early clearance and clear clinical value of detection and triage algorithms.
North America dominated the market with approximately 40.73% share in 2025, supported by regulatory maturity and early health system adoption. Asia Pacific is the fastest-growing region with a projected CAGR of 24.26% from 2026 to 2035.